- Published at
- by benzinga.com
positive
positive
Mesoblast Added to S&P/ASX 200 INDEX - Mesoblast (NASDAQ:MESO)
NEW YORK, March 06, 2025 (GLOBE NEWSWIRE) -- Mesoblast Limited (NASDAQ:MESO, ASX:MSB)), global leader in allogeneic cellular medicines for inflammatory diseases, today announced its addition to the S&P Dow Jones